Rivaroxaban NOBEL vascular
Rivaroxaban NOBEL vascular is a generic from NOBEL Pharma Schweiz AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 45.60 to CHF 118.55 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- NOBEL Pharma Schweiz AG
- ATC code
- B01AF01
- IT group
- 06.03.40 Faktor-Xa-Inhibitoren
- Active substances
- Rivaroxabanum
- Preparation type
- Generic
- On the SL since
- 01/03/2026
- Last price change
- 01/03/2026
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 2.5 mg | Blist 56 Stk | CHF 26.83 | CHF 45.60 | 01/03/2026 | B | 7680680210017 |
| Filmtabl 2.5 mg | Blist 196 Stk | CHF 93.92 | CHF 118.55 | 01/03/2026 | B | 7680680210024 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Im Fall von chronischer koronarer Herzkrankheit und Alter • Dokumentierte Atherosklerose unter Beteiligung von mindestens zwei Gefässbetten oder
• mindestens zwei zusätzlichen kardiovaskulären Risikofaktoren wie
- Diabetes mellitus
- Niereninsuffizienz ( - Herzinsuffizienz
- Nicht-lakunärer ischämischer Schlaganfall ≥1 Monat
- Rauchen
Die erweiterte Behandlung mit Rivaroxaban NOBEL vascular über 2 Jahre hinaus bedarf einer erneuten Evaluierung des Nutzen-Risiko-Profils des Patienten.
More preparations in this group
FAQ
Is Rivaroxaban NOBEL vascular covered by Swiss health insurance?
Yes, but only under conditions. Rivaroxaban NOBEL vascular is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Rivaroxaban NOBEL vascular cost in Switzerland?
The public price is the maximum price set by the FOPH and for Rivaroxaban NOBEL vascular ranges from CHF 45.60 to CHF 118.55 per pack. The ex-factory price ranges from CHF 26.83 to CHF 93.92. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages